Genor Completes $371 Million Hong Kong IPO; Market Cap Reaches $1.8 Billion
publication date: Oct 7, 2020
Genor Biopharma of Shanghai raised $371 million in its Hong Kong IPO, pricing the offering at the top of the range. In early trading, Genor rose 22%, giving the company a market capitalization of $1.8 billion. Founded in 2007, Genor has a portfolio of 15 mAbs and recombinant fusion proteins, comprising novel drugs and biosimilars that target indications in cancer, metabolic and autoimmune diseases. Hillhouse, which led a $160 million Series B financing in Genor earlier this year, owns 30% of the company's shares post-IPO. More details....
Stock Symbol: (HK: 6998)
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.